Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2) Peptide
SLC27A2
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN940523
$398.38
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 16 to 22 Business Days
Quick Overview for Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2) Peptide (ABIN940523)
Target
SLC27A2
(Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- LLFRDETLTY AQVDRRSNQV ARALHDHLGL RQGDCVALLM GNEPAYVWLW
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC27 A2 antibody,
Alternative Names: SLC27A2 control peptide, SLC27A2 antibody Blocking Peptide, Anti-SLC27A2 Blocking Peptide, Solute Carrier Family 27 Member 2 Blocking Peptide, Fatty Acid Transporter 2 Blocking Peptide, ACSVL1 Blocking Peptide, FACVL1 Blocking Peptide, FATP2 Blocking Peptide, HsT17226 Blocking Peptide, VLACS Blocking Peptide, VLCS Blocking Peptide, hFACVL1 Blocking Peptide, SLC27A2, SLCA2-27, SLCA2 27, SLCA2-27 Blocking Peptide, SLCA2 27 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))
-
Background
- SLC27A2 is an isozyme of long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme activates long-chain, branched-chain and very-long-chain fatty acids containing 22 or more carbons to their CoA derivatives. It is expressed primarily in liver and kidney, and is present in both endoplasmic reticulum and peroxisomes, but not in mitochondria. Its decreased peroxisomal enzyme activity is in part responsible for the biochemical pathology in X-linked adrenoleukodystrophy.
-
Molecular Weight
- 70 kDa
Target
-
You are here:
